Baclofen toxicosis in dogs and cats: 145 cases (2004–2010)
Authors:
- Roxanna KhorzadRKRoxanna Khorzad
- Justine A. LeeJLJustine A. Lee
- Megan WhelanMWMegan Whelan
- Ahna G. BrutlagABAhna G. Brutlag
- Elizabeth P. MartinEMElizabeth P. Martin
- Lee T. MiyaharaLMLee T. Miyahara
- Lynn R. HovdaLHLynn R. Hovda
- 15 October 2012
- journal article
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 241 (8) , 1059-1064
Abstract
Objective—To identify dogs and cats with baclofen toxicosis and characterize the patient population, clinical signs, and outcome. Design—Retrospective case series. Animals—140 dogs and 5 cats with baclofen toxicosis. Procedures—An animal poison control center electronic database was reviewed from November 2004 through April 2010 to identify dogs and cats with baclofen toxicosis. Information on signalment, clinical signs, and amount of baclofen ingested was obtained. Clinical signs were categorized as CNS, gastrointestinal, general malaise, cardiovascular, respiratory, or urogenital. Follow-up communications were performed to determine overall outcome. Results—Dogs had a median age of 0.67 years (range, 0.1 to 15 years) and cats of 1 year (range, 0.7 to 16 years). Of 145 patients, 133 (92%) developed clinical signs of baclofen toxicosis. A total of 259 signs fell within defined categories: CNS (121/259 [46.7%]), gastrointestinal (69/259 [26.6%]), general malaise (27/259 [10.4%]), cardiovascular (23/259 [8.9%]), respiratory (14/259 [5.4%]), and urogenital (5/259 [1.9%]). For 68 dogs with known survival status, survival rate was 83.8% (57/68); of these dogs, the amount of baclofen ingested was known for 53 (46 survivors and 7 nonsurvivors). Amount of baclofen ingested was significantly lower in survivor dogs (median, 4.2 mg/kg [1.91 mg/lb]; range, 0.61 to 61 mg/kg [0.28 to 27.7 mg/lb]), compared with nonsurvivor dogs (median, 14 mg/kg [6.4 mg/lb]; range, 2.3 to 52.3 mg/kg [1.04 to 23.77 mg/lb]. Of 5 cats, 2 survived, 1 died, and 2 had unknown outcomes. Conclusions and Clinical Relevance—Clinical signs of baclofen toxicosis occurred in most patients, with the CNS being the system most commonly affected.Keywords
This publication has 22 references indexed in Scilit:
- Use of intravenous lipid emulsion to treat ivermectin toxicosis in a Border CollieJournal of the American Veterinary Medical Association, 2011
- The use of intravenous lipid emulsion as an antidote in veterinary toxicologyJournal of Veterinary Emergency and Critical Care, 2011
- Treatment of a dog with severe baclofen intoxication using hemodialysis and mechanical ventilationJournal of Veterinary Emergency and Critical Care, 2008
- Baclofen intoxication in a dog successfully treated with hemodialysis and hemoperfusion coupled with intensive supportive careJournal of Veterinary Emergency and Critical Care, 2007
- Inhibitory effects of GABAB receptor agonists on swallowing in the dogEuropean Journal of Pharmacology, 2002
- Effects of repeated administration of baclofen on transient lower esophageal sphincter relaxation in the dogEuropean Journal of Pharmacology, 2000
- Presumptive Baclofen Intoxication in a DogJournal of Veterinary Emergency and Critical Care, 1998
- Plasma and urinary excretion kinetics of oral baclofen in healthy subjectsEuropean Journal of Clinical Pharmacology, 1989
- Pharmacokinetics In Baclofen OverdoseJournal of Toxicology: Clinical Toxicology, 1984
- BaclofenDrugs, 1974